Demographic shifts in Southeast Asia (SEA) have increased the demand for diagnostics and pharmaceuticals, highlighting the need for improved access and affordability. Diagnostics and treatment access inequalities, especially in rural areas, pose significant challenges to achieving universal health coverage (UHC).